Results 11 to 20 of about 433,923 (290)
Aquaporins in pancreatic ductal adenocarcinoma
APMIS, 2021 Aquaporins are water channel proteins facilitating passive transport of water across cellular membranes. Aquaporins are over‐ or ectopically expressed in a multitude of cancers, including pancreatic ductal adenocarcinoma, which is a highly aggressive cancer with low survival rate. Evidence suggests that aquaporins can affect multiple cellular processes
Anne Sofie, Bruun-Sørensen +4 more
openaire +3 more sources
Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. [PDF]
PLoS ONE, 2016 BACKGROUND:Pancreatic cancer is both common and highly lethal and therefore new biomarkers or potential targets for treatment are needed. Loss of BRCA associated protein-1 (BAP1) expression has been found in up to a quarter of intrahepatic ...
Michael Tayao +9 more
doaj +3 more sources
Features of immunophenotype of pancreatic ductal adenocarcinoma
Zaporožskij Medicinskij Žurnal, 2014 Aim. To determine features of immunophenotype of pancreatic ductal adenocarcinoma. Methods and results. At the immunohistochemical research of biopsy and postoperative material of 120 patients with pancreatic ductal adenocarcinoma the expression ...
A. V. Evseyev
doaj +2 more sources
Syndecans and Pancreatic Ductal Adenocarcinoma [PDF]
Biomolecules, 2021 Pancreatic Ductal Adenocarcinoma (PDAC) is a fatal disease with poor prognosis because patients rarely express symptoms in initial stages, which prevents early detection and diagnosis. Syndecans, a subfamily of proteoglycans, are involved in many physiological processes including cell proliferation, adhesion, and migration.
Betriu, Nausika +4 more
openaire +4 more sources
Models of pancreatic ductal adenocarcinoma [PDF]
Cancer and Metastasis Reviews, 2021 AbstractAlthough pancreatic cancer remains to be a leading cause of cancer-related deaths in many industrialized countries, there have been major advances in research over the past two decades that provided a detailed insight into the molecular and developmental processes that govern the genesis of this highly malignant tumor type.
Rayane Dennaoui +2 more
openaire +2 more sources
Classical monocytes from patients with pancreatic ductal adenocarcinoma exhibit a significantly altered transcriptome profile compared with healthy volunteers [PDF]
, 2014 The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the authorPancreatic Ductal Adenocarcinoma (PDAC) affects approximately 8000 people every ...
Cook, Jenny Anne
core +4 more sources
Pancreatic Ductal Adenocarcinoma [PDF]
Mayo Clinic Proceedings, 2017 Pancreatic ductal adenocarcinoma is ranked fourth in cancer-causing deaths. Most cases of pancreatic cancer are advanced and unresectable at the time of diagnosis due to their delayed symptomatic presentation. PET/MR imaging has a high sensitivity and specificity for detecting malignant pancreatic lesions and provides superior soft tissue detail to ...
+5 more sources
Ductal Pancreatic Adenocarcinoma [PDF]
Deutsches Ärzteblatt international, 2014 Ductal adenocarcinoma of the pancreas is the fourth most common cause of death from cancer in men and women in Germany: about 15 000 persons die of this disease each year.The S3 guideline on exocrine pancreatic carcinoma was updated with the aid of systematic literature reviews on the surgical, neoadjuvant, and adjuvant treatment of ductal pancreatic ...
Seufferlein, Thomas +5 more
openaire +2 more sources
Pancreatic Ductal Adenocarcinoma [PDF]
, 2020 The most frequent indication for pancreatic fine-needle aspiration sampling is to confirm or exclude a pancreatic ductal adenocarcinoma (PDAC). PDAC is the most common malignant neoplasm of the pancreas, and the term pancreatic cancer typically connotes this entity.
Jasreman, Dhillon, Michel, Betancourt
openaire +3 more sources
Pancreatic ductal adenocarcinoma staging [PDF]
Cancer Imaging, 2013 In addition to clinical history and evaluations, the results of laboratory tests and imaging studies help clinicians in determining treatment strategies. Imaging plays a central role in the management of oncology patients including the initial diagnosis, staging, and follow-up to assess treatment response. Historically, radiologists have relied on free-
Al-Hawary, Mahmoud M., Francis, Isaac R.
openaire +2 more sources